Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery-Reference-Cited by-同舟云学术

Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery

Published:2022-08 Issue:8 Volume:27 Page:2100-2120
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Wang Wei,Ouyang Defang

Funder

Fundo para o Desenvolvimento das Ciências e da Tecnologia

Universidade de Macau

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference190 articles.

1. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development;Jones;CPT Pharmacometrics Syst Pharmacol,2013

2. Applied concepts in PBPK modeling: how to build a PBPK/PD model;Kuepfer;CPT Pharmacometrics Syst Pharmacol,2016

3. Application of pharmacokinetic-pharmacodynamic modeling in drug delivery: development and challenges;Zou;Front Pharmacol,2020

4. Kinetics of distribution of substances administered to the body, I: the extravascular modes of administration;Teorell;Arch Int Pharmacodynamie Ther,1937

5. PBPK models for the prediction of in vivo performance of oral dosage forms;Kostewicz;Eur J Pharm Sci,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in 177Lu-PSMA Therapy;Cancers;2024-09-10

2. Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel disease;European Journal of Pharmaceutical Sciences;2024-08

3. Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics;Vaccines;2024-07-16

4. Modeling on in vivo disposition and cellular transportation of RNA lipid nanoparticles via quantum mechanics/physiologically-based pharmacokinetic approaches;Acta Pharmaceutica Sinica B;2024-07

5. Model‐informed Drug Development ( MIDD ) Regarding Regulatory Requirements and Thinking;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21